Magno Maciel-Magalhães has a total of 54 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Comparative Analysis of Zinc Oxide as Nanoparticles and Its Bulk Form through In Vitro Toxicogenetics and In Vivo Zebrafish Embryotoxicity Models

    by Carlos Fernando Araujo-Lima, Magno Maciel-MagalhãeS, Marcela Correia da Rocha Honorato, Hana de Jesús Galiza Gomes, Pedro Paulo Saldanha Coimbra, Nayara CecílIa Do Couto Guedes, Thiago dos Santos Cabral-Rocha, Lays Souza, BárBara Verena Dias Galvão, Beatriz Rodrigues Canabarro, et al.

    Zinc oxide nanoparticles (ZnO-NP) are widely used due to their enhanced biological activity compared to the bulk counterpart (ZnO-BK), raising concerns about potential toxic effects on living organisms and the environment. This study investigated the toxicity of ZnO-NP and ZnO-BK using alternative in vitro and in vivo models. The Salmonella/Microsome assay (±metabolic activation) was conducted according to the Organisation for Economic Co-operation and Development (OECD) guidelines. HepG2 cell viability and genotoxicity were assessed using the WST-1 and cytokinesis-block micronucleus (CBMN) assays. Acute toxicity was evaluated using the fish embryotoxicity (FET) test in zebrafish (Danio rerio) embryos. Both forms induced mutagenic responses in TA98 and TA102 strains, while ZnO-BK showed mutagenicity in TA100 only in the absence of metabolic activation. In HepG2 cells, both forms induced dose-dependent cytotoxicity in the WST-1 model, with ZnO-BK exhibiting greater cytotoxic potency. The CBMN assay revealed higher cytogenetic damage for ZnO-BK, including micronuclei, nuclear buds, and nucleoplasmic bridges, while both forms exhibited dose-dependent cytotoxic and cytostatic effects. In vivo, ZnO-NP exerted a more pronounced impact on embryonic development, altering eye diameter and body size compared to ZnO-BK. Overall, both forms demonstrated significant toxicological effects, highlighting their relevance for regulatory toxicogenetics and environmental safety.

  • Open Access

    Cocaine and benzoylecgonine in urban rivers: Occurrence, developmental toxicity and oxidative stress in zebrafish embryos

    by Gabriel de Farias Araujo, Lais Silva de Oliveira Costa, Vanessa Farelo dos Santos, Deivisson Lopes Cunha, Rodrigo Coutinho da Silva, Marcia Marques, Magno Maciel-Magalhães, Renata Jurema Medeiros, Henrique Marcelo Gualberto Pereira, Fabio Verissimo Correia, et al.

  • Open Access

    Enhanced Skin Delivery of Amphotericin B: Development and Evaluation of Polymeric Nanoparticles Using a Porcine Ear Model

    by Magno Maciel-Magalhães, David Emanuel Ybarra, Daniela Maza Vega, Ayelen Morena Sosa, Beatriz Rodrigues Canabarro, Flavia Fernandes Ferreira da Silva, Helvécio Vinícius Antunes Rocha, Carolina Soledad Martinez, Maria Jimena Prieto, Isabella Fernandes Delgado, et al.

    Amphotericin B (AmB) is a widely used antifungal drug that is also prescribed to some neglected diseases, such as leishmaniasis. Its usage is limited by its low oral bioavailability and side effects, leading to the exploration of alternative delivery systems. Polymeric nanoparticles (PNPs) have emerged as a promising drug delivery pathway, offering potential benefits such as controlled release and improved drug bioavailability. In this work, AmB-loaded poly­(lactic acid) (PLA) and polycaprolactone (PCL) PNPs were produced by nanoprecipitation and characterized by dynamic light scattering, scanning transmission electron microscopy, and Raman spectroscopy. Subsequently, their stability was tested in static multiple light scattering (SMLS) analysis, and their penetrability was determined in an ex vivo porcine skin model. The obtained results indicated that the PNPs were successfully produced. The PLA + AmB PNPs were able to reach the viable epidermis, while the PCL + AmB PNPs permeated the stratum corneum, suggesting that both may be useful for the topical treatment of fungal infections and cutaneous leishmaniasis.


  • Open Access

    Amphotericin B Encapsulation in Polymeric Nanoparticles: Toxicity Insights via Cells and Zebrafish Embryo Testing

    by Magno Maciel-Magalhães, Renata Jurema Medeiros, Nayara Cecília Do Couto Guedes, Thais Morais de Brito, Gabriele Fátima de Souza, Beatriz Rodrigues Canabarro, Fausto Klabund Ferraris, Fábio Coelho Amendoeira, Helvécio Vinicius Antunes Rocha, Beatriz Ferreira de Carvalho Patricio, et al.

    Background: Amphotericin B (AmB) is a commonly utilized antifungal agent, which is also recommended for the treatment of certain neglected tropical diseases, including leishmaniasis. However, its clinical application is constrained because of its poor oral bioavailability and adverse effects, prompting the investigation of alternative drug delivery systems. Polymeric nanoparticles (PNPs) have gained attention as a potential drug delivery vehicle, providing advantages such as sustained release and enhanced bioavailability, and could have potential as AmB carriers. However, concerns persist regarding nanomaterials’ toxicity, requiring more studies. Zebrafish (Danio rerio) embryos were used as a valuable model for toxicity testing, especially because of their genetic similarity to humans and standardized developmental assessments. Methods: In this study, we produced and characterized AmB loaded and non-loaded PNPs by nanoprecipitation, dynamic light scattering, transmission electron microscopy, atomic force microscopy and spectroscopy. Afterwards, we verified their toxicity through in vitro MTT assays in three cell lines (HEK293, HepG2, and J774 A1) and in vivo tests with zebrafish embryos. Results: In both trials, it was noted that nanoencapsulation of the drug led to increased toxicity when compared to non-encapsulated AmB, possibly indicating that they penetrated the embryo’s chorion. Nevertheless, it was demonstrated that the polymers used are safe and they are not the cause of toxicity, neither are the nanostructures per se. Conclusions: Therefore, it is believed that the objective of improving the bioavailability of AmB may have been achieved, and the observed toxicity was probably linked to AmB’s ability to destabilize cell membranes.


  • Open Access

    Importância da inserção de grupo controle em ensaios utilizando animais de laboratório

    by Jussara Simmer Bravin, Fundação Oswaldo Cruz (Fiocruz) Instituto Nacional de Controle de Qualidade Em Saúde (Incqs), Magno Maciel-Magalhães, Yasmin da Silva Gomes Pinheiro, Miguel Ângelo Brück Gonçalves, Fausto Klabund Ferraris, Fábio Coelho Amendoeira, Fundação Oswaldo Cruz (Fiocruz) Instituto Oswaldo Cruz (Ioc)

    Introdução: O uso de animais de laboratório é fundamental em áreas em que ainda não podem ser substituídos na totalidade, como a toxicologia. Em estudos que se utilizam, para fins de comparação, apenas dados fornecidos pelos laboratórios de análises clínicas, na tentativa de reduzir o número de animais de um experimento, arrisca-se utilizar informações que não correspondem à realidade. Objetivo: Debater o uso de grupo controle em experimentos com animais. Método: Este artigo comparou valores hematológicos e bioquímicos de ratos da linhagem Wistar, obtidos em três biotérios de criação de diferentes estados brasileiros, com os resultados de animais provindos do Instituto de Ciência e Tecnologia em Biomodelos da Fundação Oswaldo Cruz, Rio de Janeiro, objetivando a discussão acerca da tomada de decisão sobre a inclusão de grupo controle em ensaios de toxicidade aguda oral. Resultados: Poucos foram os parâmetros que não apresentaram diferenças estatísticas, tais como: hemácia em fêmeas (duas referências), hemoglobina em fêmeas (uma referência) e machos (uma referência), hematócrito nos machos (duas referências) e hemoglobina corpuscular média nas fêmeas (duas referências), leucócitos nos machos (uma referência), creatinina e alanina aminotransferase (ALT) em todas as fêmeas. Conclusões: O uso do grupo controle se faz necessário quando valores analisados preliminarmente apresentam-se discrepantes daqueles tidos como referenciais da espécie.


  • Evaluation of acute toxicity and copper accumulation in organs of Wistar rats, 14 days after oral exposure to copper oxide (II) nano- and microparticles

    by Magno Maciel-Magalhães, Renata J. Medeiros, Jussara S. Bravin, Beatriz F. C. Patricio, Helvécio V. A. Rocha, Elan C. Paes-De-Almeida, Lisia M. G. Santos, Silvana C. Jacob, Tiago C. M. Savignon, Fábio C. Amendoeira